A new Tufts University study finds that not getting enough vitamin K may harm brain health as people get older. The research, published in The Journal of Nutrition and conducted …
"dementia"
-
-
A new analysis of data from over 400,000 older adults suggests that regularly using smartphones, computers, and other digital tools may actually help preserve mental sharpness as people age. Researchers …
-
A new study suggests that lifting weights and bodyweight exercises could be the key to better sleep for older adults. Researchers from Mahidol University in Thailand analyzed data from over …
-
New research from the United Kingdom reveals that excessive use of acetaminophen—commonly known as Tylenol—may pose significant health risks for older adults. The study highlights potential dangers for seniors who …
-
New research has revealed that hidden fat around internal organs, known as visceral fat, may serve as an early warning sign for Alzheimer’s disease, up to 20 years before symptoms …
-
America NowElection 2024
At 78, Trump’s Stamina Impresses Experts: A Testament to Resilience and Vitality
As Donald Trump prepares to return to the White House, his stamina at age 78 is impressing medical experts. Trump’s energy and relentless schedule — including 120 rallies and events …
-
HealthNews
Patients with Type 2 Diabetes on Ozempic Found to Have ‘Significantly Lower Risk’ of Alzheimer’s
A recent study from Case Western Reserve University in Cleveland, Ohio, suggests that the diabetes drug Ozempic and other semaglutide medications may significantly reduce the risk of Alzheimer’s disease in …
-
The American Stroke Association (ASA) has released new guidelines to help lower the risk of strokes, focusing on prevention through screening and lifestyle changes. Strokes are the fifth-leading cause of …
-
A new study has revealed that a cutting-edge blood test can diagnose Alzheimer’s disease with over 90% accuracy, offering a promising alternative to current diagnostic methods. Conducted by researchers at …
-
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …